CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

Somatostatin receptor positive (SSTR+)

Gene: SSTR2 · Type: expression

Indications: Neuroendocrine tumor

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
Lutetium Lu 177 dotatateNeuroendocrine tumorINDICATED
FDA Label
Label